- RON4.51bn
- RON6.28bn
- RON2.72bn
- 73
- 14
- 97
- 69
Annual income statement for Med Life SA, fiscal year end - December 31st, RON millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,077 | 1,427 | 1,795 | 2,210 | 2,716 |
| Cost of Revenue | |||||
| Gross Profit | 887 | 1,087 | 1,274 | 1,612 | 1,990 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 968 | 1,255 | 1,701 | 2,119 | 2,575 |
| Operating Profit | 109 | 172 | 94.2 | 91.5 | 140 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 78.6 | 135 | 49.6 | 4.3 | 39.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 63.8 | 113 | 37.4 | -4.16 | 16.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 56.7 | 103 | 32.2 | 3.68 | 25 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 56.7 | 103 | 32.2 | 3.68 | 25 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.101 | 0.194 | 0.058 | 0.013 | 0.053 |
| Dividends per Share |